Detalhe da pesquisa
1.
CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory.
Proc Natl Acad Sci U S A
; 119(7)2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35140181
2.
Preclinical antitumor activity of S-222611, an oral reversible tyrosine kinase inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2.
Cancer Sci
; 105(8): 1040-8, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24837299
3.
Endogenous angiogenesis inhibitor vasohibin1 exhibits broad-spectrum antilymphangiogenic activity and suppresses lymph node metastasis.
Am J Pathol
; 176(4): 1950-8, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20133819
4.
Combination therapy of interleukin-2 and sorafenib improves survival benefits and prevents spontaneous pulmonary metastasis in murine renal cell carcinoma models.
Jpn J Clin Oncol
; 40(6): 503-7, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20106881
5.
Antitumor efficacy of recombinant human interleukin-2 combined with sorafenib against mouse renal cell carcinoma.
Jpn J Clin Oncol
; 39(5): 303-9, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19336449
6.
Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis.
J Clin Invest
; 114(7): 898-907, 2004 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-15467828
7.
Augmented anti-metastatic efficacy of a selective matrix metalloproteinase inhibitor, MMI-166, in combination with CPT-11.
Clin Exp Metastasis
; 19(6): 519-26, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12405289
8.
Preclinical combination chemotherapy of nedaplatin with gemcitabine against gemcitabine-refractory human lung cancer.
Cancer Lett
; 182(1): 61-8, 2002 Aug 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-12175524
9.
Augmented growth inhibition of B16-BL6 melanoma by combined treatment with a selective matrix metalloproteinase inhibitor, MMI-166, and cytotoxic agents.
Anticancer Res
; 22(6A): 3253-9, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12530072